Urea Breath Testing Market: Growth, Trends, and Future Outlook
The Urea Breath Testing Market is growing as more healthcare practitioners use non-invasive diagnostic procedures to diagnose Helicobacter pylori (H. pylori) infection. Urea Breath Testing (UBT) is an easy way to detect current H. pylori infection and facilitate post-treatment monitoring without invasive endoscopic procedures.
The global urea breath testing market was valued at USD 480 million in 2025 and is expected to reach USD 895 million by 2035, expanding at a CAGR of 6.20% from 2026 to 2035.
Growing Need for H. pylori Diagnosis
The rising prevalence of H. pylori infection significantly drives the demand for urea breath testing. This bacterium is linked to various gastrointestinal issues, such as gastritis and peptic ulcers, and poses a considerable risk for gastric cancer.
Growing understanding of the long-term implications of untreated infection encourages healthcare providers to prioritize early detection and treatment monitoring. As the focus on gastrointestinal disease management and stomach cancer prevention grows, non-invasive diagnostic tools become more viable.
Why Noninvasive Testing Is Gaining Popularity
Traditional diagnostic methods may include endoscopy and biopsy, which necessitate specialized facilities, skilled personnel, and additional healthcare resources. Urea Breath Testing offers a non-invasive option that may be integrated into diagnostic workflows in hospitals, diagnostic centers, and other healthcare facilities.
The increased preference for patient-friendly, accurate, and convenient diagnostic techniques is projected to drive further acceptance of UBT, especially as healthcare systems prioritize earlier illness diagnosis and enhanced patient experiences.
The 13C-Urea breath test dominates the market.
By test type, the 13C-Urea Breath Test dominated the market in 2025, accounting for 84.00% of the total. The 14C-Urea Breath Test was responsible for the remaining 16.00%.
The 13C test's strong position is backed by the fact that it is non-radioactive and can be repeated. This makes it a significant choice for healthcare providers looking for non-invasive methods of detecting active H. pylori and monitoring treatment outcomes.
H. pylori Screening remains the largest application.
H. pylori screening had the highest application share (57.00% in 2025), followed by post-treatment monitoring and research applications.
The growing knowledge of H. pylori-associated gastrointestinal problems is motivating more healthcare providers to include testing in their diagnostic and treatment plans. UBT can also help confirm infection clearance after therapy, increasing demand beyond initial diagnosis.
Hospitals and Diagnostic Centers Drive End-User Demand
Hospitals and diagnostic centers accounted for 63.00% of the market in 2025, owing to their high patient volumes, specialized healthcare staff, and access to diagnostic equipment.
However, the rise of primary care and decentralized diagnostic services may provide additional prospects for UBT adoption. Portable and simplified testing platforms may help to expand testing capabilities to outpatient clinics and healthcare facilities with limited laboratory infrastructure.
North America dominates the urea breath testing market.
North America had the greatest geographical share of 29.40% in 2025, with a market value of around USD 141 million.
The region benefits from modern healthcare infrastructure, established gastroenterology services, increased knowledge of H. pylori infection, and extensive access to non-invasive testing methods. The United States dominated North America, accounting for around 88.50% of the regional market in 2025.
Asia Pacific Has Significant Growth Potential
In 2025, Asia Pacific accounted for 29.60% of the global market and is predicted to continue to be one of the fastest-growing regions.
The regional urea breath testing market is expected to grow from USD 142 million in 2025 to USD 316 million in 2035. Increasing healthcare expenditure, a significant H.pylori load in some countries, rising awareness of gastrointestinal disorders, and developing diagnostic facilities are all projected to drive regional demand.
China, India, Japan, and South Korea are key markets in the region, and rising healthcare access in Southeast Asian countries may generate further potential.
Point-of-Care Testing Generates New Opportunities
The development of portable and point-of-care urea breath testing systems creates a significant opportunity for market participants. Healthcare professionals are increasingly looking for diagnostic solutions that enable efficient testing closer to patients.
Simplified UBT platforms could help drive adoption in primary care clinics, outpatient centers, community healthcare facilities, and underprivileged areas with limited centralized laboratory infrastructure.
Digital connectivity also allows for the integration of diagnostic results with electronic health records and other healthcare platforms, which could improve information exchange and clinical decision-making.
Market Challenges
Despite the strong growth potential, a number of obstacles may prevent widespread adoption. The high cost of UBT technology can be prohibitive for smaller diagnostic centers and healthcare facilities, especially in low- and middle-income regions.
UBT systems may necessitate specific instruments, laboratory infrastructure, calibration, trained people, maintenance, and quality assurance methods. Limited access to advanced healthcare infrastructure in rural and underprivileged areas may further limit market penetration.
Future Outlook
The Urea Breath Testing Market is predicted to grow as healthcare systems prioritize early H. pylori identification, non-invasive diagnostics, treatment monitoring, and increased access to gastrointestinal testing.
The market is expected to rise from USD 480 million in 2025 to USD 895 million by 2035, as innovation focuses on portable testing equipment, increased workflow efficiency, digital integration, and more accessibility.
As knowledge of H. pylori-related disorders grows and diagnostic infrastructure builds in emerging nations, Urea Breath Testing is predicted to remain a key part of the worldwide H. pylori diagnostic landscape.
Explore the Full Market Analysis.
TheUrea Breath Testing Market Report provides full market size and forecast statistics, test type and application segmentation, geographical analysis, market dynamics, opportunities, competition insights, and a strategic outlook.
